EIR GlaxoSmithKline Aug 2009

Thomas Berry FDA, Joanne Gabay FDA$595.00 - Available Now

FDA investigators audited the GlaxoSmithKline - Zebulon, NC, United States facility and issued inspectional observation (via FDA 483) on 24 Aug 2009.

Product details

  • Category:
  • Inspection end: 24 Aug 2009
  • Location: Zebulon, United States
  • FEI: 1033964
Add To Cart